C

Castle Biosciences
D

CSTL

25.730
USD
-0.43
(-1.64%)
مغلق
حجم التداول
13,614
الربح لكل سهم
-2
العائد الربحي
-
P/E
123
حجم السوق
720,627,855
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    CL
    CL
    1.604
    (1.83%)
    89.474 USD
    C
    CLX
    4.220
    (2.76%)
    157.300 USD
    C
    CPB
    1.240
    (3.15%)
    40.580 USD
    HSY
    HSY
    6.790
    (4.09%)
    172.980 USD
    KHC
    KHC
    0.985
    (3.27%)
    31.140 USD
    KMB
    KMB
    1.300
    (0.94%)
    140.280 USD
    MKC
    MKC
    0.950
    (1.20%)
    80.150 USD
    N
    NWL
    -0.02000
    (-0.29%)
    6.79500 USD
    PG
    PG
    3.000
    (1.79%)
    170.240 USD
    المزيد
الأخبار
المقالات

العنوان: Castle Biosciences

القطاع: Healthcare
الصناعة: Diagnostics & Research
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.